ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

12,627Medicare Part D Prescriptions Filled, Including Refills

Rank: 153 out of 680

$689K Total Retail Price of All Prescriptions

Rank: 165 out of 680

552 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
43% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Louisiana
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 552 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

18% of this provider’s 552 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

2% of this provider’s 10,745 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$55 was the average price of a prescription from this provider, compared to $59 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Louisiana
AMLODIPINE BESYLATE 516 476 1 1
SIMVASTATIN 455 391 2 3
LEVOTHYROXINE SODIUM 436 369 3 2
LISINOPRIL 369 324 4 5
OMEPRAZOLE 344 305 5 7
HYDROCODONE-ACETAMINOPHEN 289 213 S3 6 4
FUROSEMIDE 288 256 7 6
METFORMIN HCL 249 205 8 8
POTASSIUM CHLORIDE 247 222 9 14
MELOXICAM 205 177 10 24
NAMENDA 203 203 11 35
ALENDRONATE SODIUM 185 185 12 32
METOPROLOL TARTRATE 171 147 13 12
DONEPEZIL HCL 170 158 14 27
PRAVASTATIN SODIUM 168 152 15 10
ESCITALOPRAM OXALATE 167 141 16 45
ATENOLOL 159 128 17 19
ATORVASTATIN CALCIUM 156 139 18 11
CITALOPRAM HBR 142 130 19 22
WARFARIN SODIUM 135 129 20 20
ZOLPIDEM TARTRATE 134 105 21 17
EXELON 134 124 21 112
METOPROLOL SUCCINATE 128 76 23 13
PANTOPRAZOLE SODIUM 123 119 24 30
NEXIUM 120 100 25 16
PAROXETINE HCL 119 94 26 76
DIGOXIN 116 116 27 58
TAMSULOSIN HCL 115 93 28 34
GABAPENTIN 111 96 29 15
BUPROPION XL 110 86 30 161
AMITRIPTYLINE HCL 109 61 R 31 47
CLOPIDOGREL 107 97 32 26
CIPROFLOXACIN HCL 107 87 32 57
SERTRALINE HCL 105 84 34 28
HYDROCHLOROTHIAZIDE 101 85 35 9
GLIPIZIDE 99 74 36 63
HYDRALAZINE HCL 92 74 37 71
LISINOPRIL-HYDROCHLOROTHIAZIDE 88 87 38 37
AMLODIPINE BESYLATE-BENAZEPRIL 85 69 39 43
ALLOPURINOL 84 73 40 33
DIOVAN 82 71 41 31
CEPHALEXIN 75 54 42 149
QUETIAPINE FUMARATE 74 64 43 64
SINGULAIR 73 55 44 91
DIOVAN HCT 73 71 44 55
KLOR-CON M20 70 58 46 61
BENICAR 70 54 46 131
TRAZODONE HCL 69 62 48 48
PREMARIN 66 60 R 49 105
MIRTAZAPINE 64 64 50 78
PROPRANOLOL HCL 64 45 50 145
AZITHROMYCIN 63 55 52 42
POLYETHYLENE GLYCOL 3350 62 56 53 62
PREDNISONE 60 57 54 50
PLAVIX 59 51 55 39
RISPERIDONE 59 36 55 80
LOVASTATIN 59 59 55 44
ISOSORBIDE MONONITRATE ER 57 49 58 59
LIPITOR 56 47 59 68
LYRICA 56 48 59 77
CLONIDINE HCL 52 50 61 36
TRAMADOL HCL 52 50 61 18
CARVEDILOL 50 48 63 23
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 28, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.